Global Generic Drugs Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Description

According to our (Global Info Research) latest study, the global Generic Drugs market size was valued at US$ 377860 million in 2024 and is forecast to a readjusted size of USD 648170 million by 2031 with a CAGR of 8.1% during review period.

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.

Market competition is not intense. Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical and Aspen are the leaders of the industry, with about 19% market shares.

North America is the largest consumption place, with a consumption market share nearly 44%. Following North America, Europe is the second largest consumption place with the consumption market share of 18%.

This report is a detailed and comprehensive analysis for global Generic Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Generic Drugs market size and forecasts, in consumption value ($ Million), 2020-2031
Global Generic Drugs market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Generic Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Generic Drugs market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Generic Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Generic Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Novartis - Sandoz, Mylan, Sun Pharmaceutical, Aspen, Fresenius Kabi, Pfizer (Hospira), Sanofi, Aurobindo, Lupin, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Generic Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Prescription
    Non-Prescription Drugs

Market segment by Application
    Hospital
    Clinic
    Others

Market segment by players, this report covers
    Teva
    Novartis - Sandoz
    Mylan
    Sun Pharmaceutical
    Aspen
    Fresenius Kabi
    Pfizer (Hospira)
    Sanofi
    Aurobindo
    Lupin
    Dr. Reddy's
    Apotex
    Cipla
    ENDO (Par Pharmaceutical)
    Stada Arzneimittel
    Krka Group
    Nichi-Iko Pharmaceutical
    Valeant
    Zydus Cadila
    Hikma
    Pharmaniaga Berhad
    Hovid Berhad
    Duopharma Biotech
    Kotra Pharma
    HOE Pharmaceutical
    Y.S.P. Industries

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Generic Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Generic Drugs, with revenue, gross margin, and global market share of Generic Drugs from 2020 to 2025.
Chapter 3, the Generic Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Generic Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Generic Drugs.
Chapter 13, to describe Generic Drugs research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Generic Drugs by Type
        1.3.1 Overview: Global Generic Drugs Market Size by Type: 2020 Versus 2024 Versus 2031
        1.3.2 Global Generic Drugs Consumption Value Market Share by Type in 2024
        1.3.3 Prescription
        1.3.4 Non-Prescription Drugs
    1.4 Global Generic Drugs Market by Application
        1.4.1 Overview: Global Generic Drugs Market Size by Application: 2020 Versus 2024 Versus 2031
        1.4.2 Hospital
        1.4.3 Clinic
        1.4.4 Others
    1.5 Global Generic Drugs Market Size & Forecast
    1.6 Global Generic Drugs Market Size and Forecast by Region
        1.6.1 Global Generic Drugs Market Size by Region: 2020 VS 2024 VS 2031
        1.6.2 Global Generic Drugs Market Size by Region, (2020-2031)
        1.6.3 North America Generic Drugs Market Size and Prospect (2020-2031)
        1.6.4 Europe Generic Drugs Market Size and Prospect (2020-2031)
        1.6.5 Asia-Pacific Generic Drugs Market Size and Prospect (2020-2031)
        1.6.6 South America Generic Drugs Market Size and Prospect (2020-2031)
        1.6.7 Middle East & Africa Generic Drugs Market Size and Prospect (2020-2031)

2 Company Profiles
    2.1 Teva
        2.1.1 Teva Details
        2.1.2 Teva Major Business
        2.1.3 Teva Generic Drugs Product and Solutions
        2.1.4 Teva Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.1.5 Teva Recent Developments and Future Plans
    2.2 Novartis - Sandoz
        2.2.1 Novartis - Sandoz Details
        2.2.2 Novartis - Sandoz Major Business
        2.2.3 Novartis - Sandoz Generic Drugs Product and Solutions
        2.2.4 Novartis - Sandoz Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.2.5 Novartis - Sandoz Recent Developments and Future Plans
    2.3 Mylan
        2.3.1 Mylan Details
        2.3.2 Mylan Major Business
        2.3.3 Mylan Generic Drugs Product and Solutions
        2.3.4 Mylan Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.3.5 Mylan Recent Developments and Future Plans
    2.4 Sun Pharmaceutical
        2.4.1 Sun Pharmaceutical Details
        2.4.2 Sun Pharmaceutical Major Business
        2.4.3 Sun Pharmaceutical Generic Drugs Product and Solutions
        2.4.4 Sun Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.4.5 Sun Pharmaceutical Recent Developments and Future Plans
    2.5 Aspen
        2.5.1 Aspen Details
        2.5.2 Aspen Major Business
        2.5.3 Aspen Generic Drugs Product and Solutions
        2.5.4 Aspen Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.5.5 Aspen Recent Developments and Future Plans
    2.6 Fresenius Kabi
        2.6.1 Fresenius Kabi Details
        2.6.2 Fresenius Kabi Major Business
        2.6.3 Fresenius Kabi Generic Drugs Product and Solutions
        2.6.4 Fresenius Kabi Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.6.5 Fresenius Kabi Recent Developments and Future Plans
    2.7 Pfizer (Hospira)
        2.7.1 Pfizer (Hospira) Details
        2.7.2 Pfizer (Hospira) Major Business
        2.7.3 Pfizer (Hospira) Generic Drugs Product and Solutions
        2.7.4 Pfizer (Hospira) Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.7.5 Pfizer (Hospira) Recent Developments and Future Plans
    2.8 Sanofi
        2.8.1 Sanofi Details
        2.8.2 Sanofi Major Business
        2.8.3 Sanofi Generic Drugs Product and Solutions
        2.8.4 Sanofi Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.8.5 Sanofi Recent Developments and Future Plans
    2.9 Aurobindo
        2.9.1 Aurobindo Details
        2.9.2 Aurobindo Major Business
        2.9.3 Aurobindo Generic Drugs Product and Solutions
        2.9.4 Aurobindo Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.9.5 Aurobindo Recent Developments and Future Plans
    2.10 Lupin
        2.10.1 Lupin Details
        2.10.2 Lupin Major Business
        2.10.3 Lupin Generic Drugs Product and Solutions
        2.10.4 Lupin Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.10.5 Lupin Recent Developments and Future Plans
    2.11 Dr. Reddy's
        2.11.1 Dr. Reddy's Details
        2.11.2 Dr. Reddy's Major Business
        2.11.3 Dr. Reddy's Generic Drugs Product and Solutions
        2.11.4 Dr. Reddy's Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.11.5 Dr. Reddy's Recent Developments and Future Plans
    2.12 Apotex
        2.12.1 Apotex Details
        2.12.2 Apotex Major Business
        2.12.3 Apotex Generic Drugs Product and Solutions
        2.12.4 Apotex Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.12.5 Apotex Recent Developments and Future Plans
    2.13 Cipla
        2.13.1 Cipla Details
        2.13.2 Cipla Major Business
        2.13.3 Cipla Generic Drugs Product and Solutions
        2.13.4 Cipla Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.13.5 Cipla Recent Developments and Future Plans
    2.14 ENDO (Par Pharmaceutical)
        2.14.1 ENDO (Par Pharmaceutical) Details
        2.14.2 ENDO (Par Pharmaceutical) Major Business
        2.14.3 ENDO (Par Pharmaceutical) Generic Drugs Product and Solutions
        2.14.4 ENDO (Par Pharmaceutical) Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.14.5 ENDO (Par Pharmaceutical) Recent Developments and Future Plans
    2.15 Stada Arzneimittel
        2.15.1 Stada Arzneimittel Details
        2.15.2 Stada Arzneimittel Major Business
        2.15.3 Stada Arzneimittel Generic Drugs Product and Solutions
        2.15.4 Stada Arzneimittel Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.15.5 Stada Arzneimittel Recent Developments and Future Plans
    2.16 Krka Group
        2.16.1 Krka Group Details
        2.16.2 Krka Group Major Business
        2.16.3 Krka Group Generic Drugs Product and Solutions
        2.16.4 Krka Group Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.16.5 Krka Group Recent Developments and Future Plans
    2.17 Nichi-Iko Pharmaceutical
        2.17.1 Nichi-Iko Pharmaceutical Details
        2.17.2 Nichi-Iko Pharmaceutical Major Business
        2.17.3 Nichi-Iko Pharmaceutical Generic Drugs Product and Solutions
        2.17.4 Nichi-Iko Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.17.5 Nichi-Iko Pharmaceutical Recent Developments and Future Plans
    2.18 Valeant
        2.18.1 Valeant Details
        2.18.2 Valeant Major Business
        2.18.3 Valeant Generic Drugs Product and Solutions
        2.18.4 Valeant Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.18.5 Valeant Recent Developments and Future Plans
    2.19 Zydus Cadila
        2.19.1 Zydus Cadila Details
        2.19.2 Zydus Cadila Major Business
        2.19.3 Zydus Cadila Generic Drugs Product and Solutions
        2.19.4 Zydus Cadila Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.19.5 Zydus Cadila Recent Developments and Future Plans
    2.20 Hikma
        2.20.1 Hikma Details
        2.20.2 Hikma Major Business
        2.20.3 Hikma Generic Drugs Product and Solutions
        2.20.4 Hikma Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.20.5 Hikma Recent Developments and Future Plans
    2.21 Pharmaniaga Berhad
        2.21.1 Pharmaniaga Berhad Details
        2.21.2 Pharmaniaga Berhad Major Business
        2.21.3 Pharmaniaga Berhad Generic Drugs Product and Solutions
        2.21.4 Pharmaniaga Berhad Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.21.5 Pharmaniaga Berhad Recent Developments and Future Plans
    2.22 Hovid Berhad
        2.22.1 Hovid Berhad Details
        2.22.2 Hovid Berhad Major Business
        2.22.3 Hovid Berhad Generic Drugs Product and Solutions
        2.22.4 Hovid Berhad Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.22.5 Hovid Berhad Recent Developments and Future Plans
    2.23 Duopharma Biotech
        2.23.1 Duopharma Biotech Details
        2.23.2 Duopharma Biotech Major Business
        2.23.3 Duopharma Biotech Generic Drugs Product and Solutions
        2.23.4 Duopharma Biotech Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.23.5 Duopharma Biotech Recent Developments and Future Plans
    2.24 Kotra Pharma
        2.24.1 Kotra Pharma Details
        2.24.2 Kotra Pharma Major Business
        2.24.3 Kotra Pharma Generic Drugs Product and Solutions
        2.24.4 Kotra Pharma Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.24.5 Kotra Pharma Recent Developments and Future Plans
    2.25 HOE Pharmaceutical
        2.25.1 HOE Pharmaceutical Details
        2.25.2 HOE Pharmaceutical Major Business
        2.25.3 HOE Pharmaceutical Generic Drugs Product and Solutions
        2.25.4 HOE Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.25.5 HOE Pharmaceutical Recent Developments and Future Plans
    2.26 Y.S.P. Industries
        2.26.1 Y.S.P. Industries Details
        2.26.2 Y.S.P. Industries Major Business
        2.26.3 Y.S.P. Industries Generic Drugs Product and Solutions
        2.26.4 Y.S.P. Industries Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.26.5 Y.S.P. Industries Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Generic Drugs Revenue and Share by Players (2020-2025)
    3.2 Market Share Analysis (2024)
        3.2.1 Market Share of Generic Drugs by Company Revenue
        3.2.2 Top 3 Generic Drugs Players Market Share in 2024
        3.2.3 Top 6 Generic Drugs Players Market Share in 2024
    3.3 Generic Drugs Market: Overall Company Footprint Analysis
        3.3.1 Generic Drugs Market: Region Footprint
        3.3.2 Generic Drugs Market: Company Product Type Footprint
        3.3.3 Generic Drugs Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Generic Drugs Consumption Value and Market Share by Type (2020-2025)
    4.2 Global Generic Drugs Market Forecast by Type (2026-2031)

5 Market Size Segment by Application
    5.1 Global Generic Drugs Consumption Value Market Share by Application (2020-2025)
    5.2 Global Generic Drugs Market Forecast by Application (2026-2031)

6 North America
    6.1 North America Generic Drugs Consumption Value by Type (2020-2031)
    6.2 North America Generic Drugs Market Size by Application (2020-2031)
    6.3 North America Generic Drugs Market Size by Country
        6.3.1 North America Generic Drugs Consumption Value by Country (2020-2031)
        6.3.2 United States Generic Drugs Market Size and Forecast (2020-2031)
        6.3.3 Canada Generic Drugs Market Size and Forecast (2020-2031)
        6.3.4 Mexico Generic Drugs Market Size and Forecast (2020-2031)

7 Europe
    7.1 Europe Generic Drugs Consumption Value by Type (2020-2031)
    7.2 Europe Generic Drugs Consumption Value by Application (2020-2031)
    7.3 Europe Generic Drugs Market Size by Country
        7.3.1 Europe Generic Drugs Consumption Value by Country (2020-2031)
        7.3.2 Germany Generic Drugs Market Size and Forecast (2020-2031)
        7.3.3 France Generic Drugs Market Size and Forecast (2020-2031)
        7.3.4 United Kingdom Generic Drugs Market Size and Forecast (2020-2031)
        7.3.5 Russia Generic Drugs Market Size and Forecast (2020-2031)
        7.3.6 Italy Generic Drugs Market Size and Forecast (2020-2031)

8 Asia-Pacific
    8.1 Asia-Pacific Generic Drugs Consumption Value by Type (2020-2031)
    8.2 Asia-Pacific Generic Drugs Consumption Value by Application (2020-2031)
    8.3 Asia-Pacific Generic Drugs Market Size by Region
        8.3.1 Asia-Pacific Generic Drugs Consumption Value by Region (2020-2031)
        8.3.2 China Generic Drugs Market Size and Forecast (2020-2031)
        8.3.3 Japan Generic Drugs Market Size and Forecast (2020-2031)
        8.3.4 South Korea Generic Drugs Market Size and Forecast (2020-2031)
        8.3.5 India Generic Drugs Market Size and Forecast (2020-2031)
        8.3.6 Southeast Asia Generic Drugs Market Size and Forecast (2020-2031)
        8.3.7 Australia Generic Drugs Market Size and Forecast (2020-2031)

9 South America
    9.1 South America Generic Drugs Consumption Value by Type (2020-2031)
    9.2 South America Generic Drugs Consumption Value by Application (2020-2031)
    9.3 South America Generic Drugs Market Size by Country
        9.3.1 South America Generic Drugs Consumption Value by Country (2020-2031)
        9.3.2 Brazil Generic Drugs Market Size and Forecast (2020-2031)
        9.3.3 Argentina Generic Drugs Market Size and Forecast (2020-2031)

10 Middle East & Africa
    10.1 Middle East & Africa Generic Drugs Consumption Value by Type (2020-2031)
    10.2 Middle East & Africa Generic Drugs Consumption Value by Application (2020-2031)
    10.3 Middle East & Africa Generic Drugs Market Size by Country
        10.3.1 Middle East & Africa Generic Drugs Consumption Value by Country (2020-2031)
        10.3.2 Turkey Generic Drugs Market Size and Forecast (2020-2031)
        10.3.3 Saudi Arabia Generic Drugs Market Size and Forecast (2020-2031)
        10.3.4 UAE Generic Drugs Market Size and Forecast (2020-2031)

11 Market Dynamics
    11.1 Generic Drugs Market Drivers
    11.2 Generic Drugs Market Restraints
    11.3 Generic Drugs Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Generic Drugs Industry Chain
    12.2 Generic Drugs Upstream Analysis
    12.3 Generic Drugs Midstream Analysis
    12.4 Generic Drugs Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Generic Drugs Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global Generic Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. Global Generic Drugs Consumption Value by Region (2020-2025) & (USD Million)
 Table 4. Global Generic Drugs Consumption Value by Region (2026-2031) & (USD Million)
 Table 5. Teva Company Information, Head Office, and Major Competitors
 Table 6. Teva Major Business
 Table 7. Teva Generic Drugs Product and Solutions
 Table 8. Teva Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 9. Teva Recent Developments and Future Plans
 Table 10. Novartis - Sandoz Company Information, Head Office, and Major Competitors
 Table 11. Novartis - Sandoz Major Business
 Table 12. Novartis - Sandoz Generic Drugs Product and Solutions
 Table 13. Novartis - Sandoz Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 14. Novartis - Sandoz Recent Developments and Future Plans
 Table 15. Mylan Company Information, Head Office, and Major Competitors
 Table 16. Mylan Major Business
 Table 17. Mylan Generic Drugs Product and Solutions
 Table 18. Mylan Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 19. Sun Pharmaceutical Company Information, Head Office, and Major Competitors
 Table 20. Sun Pharmaceutical Major Business
 Table 21. Sun Pharmaceutical Generic Drugs Product and Solutions
 Table 22. Sun Pharmaceutical Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 23. Sun Pharmaceutical Recent Developments and Future Plans
 Table 24. Aspen Company Information, Head Office, and Major Competitors
 Table 25. Aspen Major Business
 Table 26. Aspen Generic Drugs Product and Solutions
 Table 27. Aspen Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 28. Aspen Recent Developments and Future Plans
 Table 29. Fresenius Kabi Company Information, Head Office, and Major Competitors
 Table 30. Fresenius Kabi Major Business
 Table 31. Fresenius Kabi Generic Drugs Product and Solutions
 Table 32. Fresenius Kabi Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 33. Fresenius Kabi Recent Developments and Future Plans
 Table 34. Pfizer (Hospira) Company Information, Head Office, and Major Competitors
 Table 35. Pfizer (Hospira) Major Business
 Table 36. Pfizer (Hospira) Generic Drugs Product and Solutions
 Table 37. Pfizer (Hospira) Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 38. Pfizer (Hospira) Recent Developments and Future Plans
 Table 39. Sanofi Company Information, Head Office, and Major Competitors
 Table 40. Sanofi Major Business
 Table 41. Sanofi Generic Drugs Product and Solutions
 Table 42. Sanofi Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 43. Sanofi Recent Developments and Future Plans
 Table 44. Aurobindo Company Information, Head Office, and Major Competitors
 Table 45. Aurobindo Major Business
 Table 46. Aurobindo Generic Drugs Product and Solutions
 Table 47. Aurobindo Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 48. Aurobindo Recent Developments and Future Plans
 Table 49. Lupin Company Information, Head Office, and Major Competitors
 Table 50. Lupin Major Business
 Table 51. Lupin Generic Drugs Product and Solutions
 Table 52. Lupin Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 53. Lupin Recent Developments and Future Plans
 Table 54. Dr. Reddy's Company Information, Head Office, and Major Competitors
 Table 55. Dr. Reddy's Major Business
 Table 56. Dr. Reddy's Generic Drugs Product and Solutions
 Table 57. Dr. Reddy's Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 58. Dr. Reddy's Recent Developments and Future Plans
 Table 59. Apotex Company Information, Head Office, and Major Competitors
 Table 60. Apotex Major Business
 Table 61. Apotex Generic Drugs Product and Solutions
 Table 62. Apotex Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 63. Apotex Recent Developments and Future Plans
 Table 64. Cipla Company Information, Head Office, and Major Competitors
 Table 65. Cipla Major Business
 Table 66. Cipla Generic Drugs Product and Solutions
 Table 67. Cipla Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 68. Cipla Recent Developments and Future Plans
 Table 69. ENDO (Par Pharmaceutical) Company Information, Head Office, and Major Competitors
 Table 70. ENDO (Par Pharmaceutical) Major Business
 Table 71. ENDO (Par Pharmaceutical) Generic Drugs Product and Solutions
 Table 72. ENDO (Par Pharmaceutical) Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 73. ENDO (Par Pharmaceutical) Recent Developments and Future Plans
 Table 74. Stada Arzneimittel Company Information, Head Office, and Major Competitors
 Table 75. Stada Arzneimittel Major Business
 Table 76. Stada Arzneimittel Generic Drugs Product and Solutions
 Table 77. Stada Arzneimittel Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 78. Stada Arzneimittel Recent Developments and Future Plans
 Table 79. Krka Group Company Information, Head Office, and Major Competitors
 Table 80. Krka Group Major Business
 Table 81. Krka Group Generic Drugs Product and Solutions
 Table 82. Krka Group Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 83. Krka Group Recent Developments and Future Plans
 Table 84. Nichi-Iko Pharmaceutical Company Information, Head Office, and Major Competitors
 Table 85. Nichi-Iko Pharmaceutical Major Business
 Table 86. Nichi-Iko Pharmaceutical Generic Drugs Product and Solutions
 Table 87. Nichi-Iko Pharmaceutical Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 88. Nichi-Iko Pharmaceutical Recent Developments and Future Plans
 Table 89. Valeant Company Information, Head Office, and Major Competitors
 Table 90. Valeant Major Business
 Table 91. Valeant Generic Drugs Product and Solutions
 Table 92. Valeant Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 93. Valeant Recent Developments and Future Plans
 Table 94. Zydus Cadila Company Information, Head Office, and Major Competitors
 Table 95. Zydus Cadila Major Business
 Table 96. Zydus Cadila Generic Drugs Product and Solutions
 Table 97. Zydus Cadila Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 98. Zydus Cadila Recent Developments and Future Plans
 Table 99. Hikma Company Information, Head Office, and Major Competitors
 Table 100. Hikma Major Business
 Table 101. Hikma Generic Drugs Product and Solutions
 Table 102. Hikma Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 103. Hikma Recent Developments and Future Plans
 Table 104. Pharmaniaga Berhad Company Information, Head Office, and Major Competitors
 Table 105. Pharmaniaga Berhad Major Business
 Table 106. Pharmaniaga Berhad Generic Drugs Product and Solutions
 Table 107. Pharmaniaga Berhad Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 108. Pharmaniaga Berhad Recent Developments and Future Plans
 Table 109. Hovid Berhad Company Information, Head Office, and Major Competitors
 Table 110. Hovid Berhad Major Business
 Table 111. Hovid Berhad Generic Drugs Product and Solutions
 Table 112. Hovid Berhad Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 113. Hovid Berhad Recent Developments and Future Plans
 Table 114. Duopharma Biotech Company Information, Head Office, and Major Competitors
 Table 115. Duopharma Biotech Major Business
 Table 116. Duopharma Biotech Generic Drugs Product and Solutions
 Table 117. Duopharma Biotech Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 118. Duopharma Biotech Recent Developments and Future Plans
 Table 119. Kotra Pharma Company Information, Head Office, and Major Competitors
 Table 120. Kotra Pharma Major Business
 Table 121. Kotra Pharma Generic Drugs Product and Solutions
 Table 122. Kotra Pharma Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 123. Kotra Pharma Recent Developments and Future Plans
 Table 124. HOE Pharmaceutical Company Information, Head Office, and Major Competitors
 Table 125. HOE Pharmaceutical Major Business
 Table 126. HOE Pharmaceutical Generic Drugs Product and Solutions
 Table 127. HOE Pharmaceutical Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 128. HOE Pharmaceutical Recent Developments and Future Plans
 Table 129. Y.S.P. Industries Company Information, Head Office, and Major Competitors
 Table 130. Y.S.P. Industries Major Business
 Table 131. Y.S.P. Industries Generic Drugs Product and Solutions
 Table 132. Y.S.P. Industries Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 133. Y.S.P. Industries Recent Developments and Future Plans
 Table 134. Global Generic Drugs Revenue (USD Million) by Players (2020-2025)
 Table 135. Global Generic Drugs Revenue Share by Players (2020-2025)
 Table 136. Breakdown of Generic Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 137. Market Position of Players in Generic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 138. Head Office of Key Generic Drugs Players
 Table 139. Generic Drugs Market: Company Product Type Footprint
 Table 140. Generic Drugs Market: Company Product Application Footprint
 Table 141. Generic Drugs New Market Entrants and Barriers to Market Entry
 Table 142. Generic Drugs Mergers, Acquisition, Agreements, and Collaborations
 Table 143. Global Generic Drugs Consumption Value (USD Million) by Type (2020-2025)
 Table 144. Global Generic Drugs Consumption Value Share by Type (2020-2025)
 Table 145. Global Generic Drugs Consumption Value Forecast by Type (2026-2031)
 Table 146. Global Generic Drugs Consumption Value by Application (2020-2025)
 Table 147. Global Generic Drugs Consumption Value Forecast by Application (2026-2031)
 Table 148. North America Generic Drugs Consumption Value by Type (2020-2025) & (USD Million)
 Table 149. North America Generic Drugs Consumption Value by Type (2026-2031) & (USD Million)
 Table 150. North America Generic Drugs Consumption Value by Application (2020-2025) & (USD Million)
 Table 151. North America Generic Drugs Consumption Value by Application (2026-2031) & (USD Million)
 Table 152. North America Generic Drugs Consumption Value by Country (2020-2025) & (USD Million)
 Table 153. North America Generic Drugs Consumption Value by Country (2026-2031) & (USD Million)
 Table 154. Europe Generic Drugs Consumption Value by Type (2020-2025) & (USD Million)
 Table 155. Europe Generic Drugs Consumption Value by Type (2026-2031) & (USD Million)
 Table 156. Europe Generic Drugs Consumption Value by Application (2020-2025) & (USD Million)
 Table 157. Europe Generic Drugs Consumption Value by Application (2026-2031) & (USD Million)
 Table 158. Europe Generic Drugs Consumption Value by Country (2020-2025) & (USD Million)
 Table 159. Europe Generic Drugs Consumption Value by Country (2026-2031) & (USD Million)
 Table 160. Asia-Pacific Generic Drugs Consumption Value by Type (2020-2025) & (USD Million)
 Table 161. Asia-Pacific Generic Drugs Consumption Value by Type (2026-2031) & (USD Million)
 Table 162. Asia-Pacific Generic Drugs Consumption Value by Application (2020-2025) & (USD Million)
 Table 163. Asia-Pacific Generic Drugs Consumption Value by Application (2026-2031) & (USD Million)
 Table 164. Asia-Pacific Generic Drugs Consumption Value by Region (2020-2025) & (USD Million)
 Table 165. Asia-Pacific Generic Drugs Consumption Value by Region (2026-2031) & (USD Million)
 Table 166. South America Generic Drugs Consumption Value by Type (2020-2025) & (USD Million)
 Table 167. South America Generic Drugs Consumption Value by Type (2026-2031) & (USD Million)
 Table 168. South America Generic Drugs Consumption Value by Application (2020-2025) & (USD Million)
 Table 169. South America Generic Drugs Consumption Value by Application (2026-2031) & (USD Million)
 Table 170. South America Generic Drugs Consumption Value by Country (2020-2025) & (USD Million)
 Table 171. South America Generic Drugs Consumption Value by Country (2026-2031) & (USD Million)
 Table 172. Middle East & Africa Generic Drugs Consumption Value by Type (2020-2025) & (USD Million)
 Table 173. Middle East & Africa Generic Drugs Consumption Value by Type (2026-2031) & (USD Million)
 Table 174. Middle East & Africa Generic Drugs Consumption Value by Application (2020-2025) & (USD Million)
 Table 175. Middle East & Africa Generic Drugs Consumption Value by Application (2026-2031) & (USD Million)
 Table 176. Middle East & Africa Generic Drugs Consumption Value by Country (2020-2025) & (USD Million)
 Table 177. Middle East & Africa Generic Drugs Consumption Value by Country (2026-2031) & (USD Million)
 Table 178. Global Key Players of Generic Drugs Upstream (Raw Materials)
 Table 179. Global Generic Drugs Typical Customers


List of Figures
 Figure 1. Generic Drugs Picture
 Figure 2. Global Generic Drugs Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global Generic Drugs Consumption Value Market Share by Type in 2024
 Figure 4. Prescription
 Figure 5. Non-Prescription Drugs
 Figure 6. Global Generic Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 7. Generic Drugs Consumption Value Market Share by Application in 2024
 Figure 8. Hospital Picture
 Figure 9. Clinic Picture
 Figure 10. Others Picture
 Figure 11. Global Generic Drugs Consumption Value, (USD Million): 2020 & 2024 & 2031
 Figure 12. Global Generic Drugs Consumption Value and Forecast (2020-2031) & (USD Million)
 Figure 13. Global Market Generic Drugs Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
 Figure 14. Global Generic Drugs Consumption Value Market Share by Region (2020-2031)
 Figure 15. Global Generic Drugs Consumption Value Market Share by Region in 2024
 Figure 16. North America Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 17. Europe Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 18. Asia-Pacific Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 19. South America Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 20. Middle East & Africa Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 21. Company Three Recent Developments and Future Plans
 Figure 22. Global Generic Drugs Revenue Share by Players in 2024
 Figure 23. Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
 Figure 24. Market Share of Generic Drugs by Player Revenue in 2024
 Figure 25. Top 3 Generic Drugs Players Market Share in 2024
 Figure 26. Top 6 Generic Drugs Players Market Share in 2024
 Figure 27. Global Generic Drugs Consumption Value Share by Type (2020-2025)
 Figure 28. Global Generic Drugs Market Share Forecast by Type (2026-2031)
 Figure 29. Global Generic Drugs Consumption Value Share by Application (2020-2025)
 Figure 30. Global Generic Drugs Market Share Forecast by Application (2026-2031)
 Figure 31. North America Generic Drugs Consumption Value Market Share by Type (2020-2031)
 Figure 32. North America Generic Drugs Consumption Value Market Share by Application (2020-2031)
 Figure 33. North America Generic Drugs Consumption Value Market Share by Country (2020-2031)
 Figure 34. United States Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 35. Canada Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 36. Mexico Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 37. Europe Generic Drugs Consumption Value Market Share by Type (2020-2031)
 Figure 38. Europe Generic Drugs Consumption Value Market Share by Application (2020-2031)
 Figure 39. Europe Generic Drugs Consumption Value Market Share by Country (2020-2031)
 Figure 40. Germany Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 41. France Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 42. United Kingdom Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 43. Russia Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 44. Italy Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 45. Asia-Pacific Generic Drugs Consumption Value Market Share by Type (2020-2031)
 Figure 46. Asia-Pacific Generic Drugs Consumption Value Market Share by Application (2020-2031)
 Figure 47. Asia-Pacific Generic Drugs Consumption Value Market Share by Region (2020-2031)
 Figure 48. China Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 49. Japan Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 50. South Korea Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 51. India Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 52. Southeast Asia Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 53. Australia Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 54. South America Generic Drugs Consumption Value Market Share by Type (2020-2031)
 Figure 55. South America Generic Drugs Consumption Value Market Share by Application (2020-2031)
 Figure 56. South America Generic Drugs Consumption Value Market Share by Country (2020-2031)
 Figure 57. Brazil Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 58. Argentina Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 59. Middle East & Africa Generic Drugs Consumption Value Market Share by Type (2020-2031)
 Figure 60. Middle East & Africa Generic Drugs Consumption Value Market Share by Application (2020-2031)
 Figure 61. Middle East & Africa Generic Drugs Consumption Value Market Share by Country (2020-2031)
 Figure 62. Turkey Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 63. Saudi Arabia Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 64. UAE Generic Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 65. Generic Drugs Market Drivers
 Figure 66. Generic Drugs Market Restraints
 Figure 67. Generic Drugs Market Trends
 Figure 68. Porters Five Forces Analysis
 Figure 69. Generic Drugs Industrial Chain
 Figure 70. Methodology
 Figure 71. Research Process and Data Source

Companies Mentioned

Teva
Novartis - Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
Pharmaniaga Berhad
Hovid Berhad
Duopharma Biotech
Kotra Pharma
HOE Pharmaceutical
Y.S.P. Industries